SecBot SecBot
SECBOTREPLAY Home › Report › ORKA

ORKA · Director intends 18K share sale

Oruka Therapeutics, Inc. · 144 filed Nov 12, 2026 at 16:19 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 12, 2026 at 16:19 ET

Director Kristine Ball filed a Form 144 notice of intent to sell 18,000 shares of Oruka Therapeutics common stock, with an estimated aggregate market value of approximately $1.93 million. The shares were acquired via stock option exercise on the same date. The sale represents a modest portion of the director's holdings and is not unusual for a director-level insider.

  • Kristine Ball, a director, filed Form 144 to sell 18,000 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $1,929,060.
  • Shares were acquired on 11/12/2026 via exercise of stock options from the issuer.
  • The proposed sale date is 11/12/2026, the same day as the filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access